These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6527242)

  • 1. Sustained-release characteristics of a new implantable formulation of disulfiram.
    Phillips M; Gresser JD
    J Pharm Sci; 1984 Dec; 73(12):1718-20. PubMed ID: 6527242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of disulfiram after injection of suspended micropellets into alcoholic subjects.
    Cid E; Cid E; Feuerhake O; Boisier I; Chandía R
    Biopharm Drug Dispos; 1991 Mar; 12(2):163-9. PubMed ID: 1851646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot preparations of disulfiram: experimental and clinical results.
    Johnsen J; Mørland J
    Acta Psychiatr Scand Suppl; 1992; 369():27-30. PubMed ID: 1471548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent sensitivity to ethanol following a single dose of parenteral sustained-release disulfiram.
    Phillips M
    Adv Alcohol Subst Abuse; 1987; 7(1):51-61. PubMed ID: 3442274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of implant tablet for a week-long sustained release.
    Takahashi M; Onishi H; Machida Y
    J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterisation of sustained release solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
    Shergill M; Patel M; Khan S; Bashir A; McConville C
    Int J Pharm; 2016 Jan; 497(1-2):3-11. PubMed ID: 26608620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of a prolonged-action antialcohol preparation.
    Konoplitskaya KL; Pkhakadze GA; Narazayko LF
    Biomaterials; 1991 Sep; 12(7):701-4. PubMed ID: 1742416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic fate of double-labeled disulfiram.
    Neiderhiser DH; Wych G; Fuller RK
    Alcohol Clin Exp Res; 1983; 7(2):199-202. PubMed ID: 6346924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders.
    Wise DL; Rosenkrantz H; Gregory JB; Esber HJ
    J Pharm Pharmacol; 1980 Jun; 32(6):399-403. PubMed ID: 6106671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of disulfiram-loaded poly(lactic-co-glycolic acid) wafers for the localised treatment of glioblastoma multiforme: a comparison of manufacturing techniques.
    Zembko I; Ahmed I; Farooq A; Dail J; Tawari P; Wang W; Mcconville C
    J Pharm Sci; 2015 Mar; 104(3):1076-86. PubMed ID: 25537972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.
    Fournier C; Hecquet B; Bouffard P; Vert M; Caty A; Vilain MO; Vanseymortier L; Merle S; Krikorian A; Lefebvre JL
    Cancer Res; 1991 Oct; 51(19):5384-91. PubMed ID: 1913658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfiram-loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer.
    Baffoe CS; Nguyen N; Boyd P; Wang W; Morris M; McConville C
    J Pharm Pharmacol; 2015 Feb; 67(2):189-98. PubMed ID: 25495604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of glucagon-like peptide-1 loaded PLGA microspheres: characterizations, release studies and bioactivities in vitro/in vivo.
    Yin D; Lu Y; Zhang H; Zhang G; Zou H; Sun D; Zhong Y
    Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):156-61. PubMed ID: 18239299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer.
    Asmus LR; Tille JC; Kaufmann B; Melander L; Weiss T; Vessman K; Koechling W; Schwach G; Gurny R; Möller M
    J Control Release; 2013 Feb; 165(3):199-206. PubMed ID: 23220105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabrication of a new composite scaffold material for delivering rifampicin and its sustained drug release in rats].
    Ma XM; Lin Z; Zhang JW; Sang CH; Qu DB; Jiang JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):309-15. PubMed ID: 27063154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Digestive absorption, fixation and excretion of oral disulfiram in the rat].
    de Saint Blanquat G; Vidaillac G; Lindenbaum A; Derache R
    Arch Int Pharmacodyn Ther; 1976 Oct; 223(2):339-50. PubMed ID: 187135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram implantation: placebo, psychological deterrent, and pharmacological deterrent effects.
    Wilson A; Davidson WJ; White J
    Br J Psychiatry; 1976 Sep; 129():277-80. PubMed ID: 786421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging study of depot disulfiram in alcohol abusers.
    Phillips M; Greenberg J
    Alcohol Clin Exp Res; 1992 Oct; 16(5):964-7. PubMed ID: 1443436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depot treatment with disulfiram].
    Holmboe AM
    Tidsskr Nor Laegeforen; 1977 Mar; 97(9-10):456-8, 472. PubMed ID: 847721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.